L. Guinement

Institut de Cancérologie de Lorraine

Papers

1

Total Citations

13

H-Index

1

About

L. Guinement is a clinical researcher specializing in the comparative evaluation of advanced stereotactic radiosurgery techniques for treating brain metastases. Their most-cited work, a 2023 study comparing the HyperArc™ and CyberKnife® technologies, has garnered 13 citations and provides critical insights into the efficacy and precision of these cutting-edge systems. By systematically analyzing dosimetric and clinical outcomes, Guinement has contributed to evidence-based decision-making in radiation oncology, helping clinicians optimize treatment planning for patients with intracranial tumors. This research holds particular significance in an era where stereotactic radiosurgery is increasingly favored for its non-invasive approach and high local control rates. Guinement’s work underscores the importance of technological comparison in advancing personalized cancer care, and their findings have been referenced in subsequent studies exploring treatment delivery and patient outcomes. Through this focused contribution, Guinement has established themselves as a thoughtful voice in the ongoing refinement of stereotactic techniques, bridging the gap between emerging technologies and practical clinical application.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Comparison between the HyperArc™ technique and the CyberKnife® technique for stereotactic treatment of brain metastases
13 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Institut de Cancérologie de Lorraine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago